MedTrace Logo

China Antiretroviral Treatment Adherence for Life

NCT00661258 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-05-15

Study results available
· View outcomes & findings →

Summary

This study focuses on collecting and analyzing quantitative data related to adherence to antiretroviral treatment from patients in Dali, China, over a one-year time-frame and generating preliminary data on an intervention designed to improve adherence to antiretroviral treatment among the study population.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Electronic drug monitoring feedback data

All patients were given electronic drug monitors that can monitor pill-taking behavior. In the intervention arm, patients and their attending doctors were given the electronic drug monitoring data on pill bottle openings at each monthly visit for use in adherence counseling sessions. Control arm patients were not given their electronic drug monitoring feedback data and their counseling sessions were based on self-reported adherence, as per standard of care in Dali.

Sponsors & Collaborators

  • Beijing Ditan Hospital

    collaborator OTHER

  • Second People's Hospital, Dali

    collaborator OTHER

  • Boston University

    lead OTHER

Principal Investigators

  • Lora L Sabin, PhD · Center for International Health and Development, Boston University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00661258 on ClinicalTrials.gov